Joint damage is an important consequence of rheumatoid arthritis and other inflammatory athritides and accounts for functional impairment and disability. The traditional view is that inflammation is the major mechanism behind the joint destruction. Therefore, the main attraction has been directed towards various inflammatory mediators. In clinical practice several indices of inflammatory activity, such as erythrocyte sedimentation rate and acute phase plasma proteins, have been considered as valuable markers. These estimates of disease activity cannot be considered as reliable predictors of progressive joint damage, however. [1] [2] [3] Thus novel markers for an understanding of the disease process are urgendy needed. It has been suggested that joint damage may result from a series of pathological changes unrelated to the inflammation.-8 Metabolically unfavourable effects on the joint structures might be secondary to altered nutrition or ischaemia, for example, and could be reflected by purine metabolites. In a previous study increased synovial fluid concentrations of hypoxanthine were reported in patients with rheumatoid arthritis. 9 In an attempt to elucidate further the nucleotide metabolism within the inflamed joint cavity we measured the synovial fluid concentrations of the oxypurines hypoxanthine, xanthine, and urate in patients with inflammatory arthritides. Data 1) were identified by comparing the peaks with the retention times for the pure substances and by the peak shift technique after adding the enzyme xanthine oxidase (Boehringer-Mannheim, Mannheim, Germany) to the specimens. Measurement of the oxypurines in synovial fluid and plasma was performed from standard curves of hypoxanthine, xanthine, and urate produced by peak height measurements of standard samples with known concentrations. The hypoxanthine and xanthine concentrations in healthy controls were 1 1 (SD 0 5) p,mol/l and 0 4 (0O1) ,umol/l, respectively. Further details of the chromatographic technique for oxypurine measurements are presented elsewhere." The inflammatory activity was estimated by measuring erythrocyte sedimentation rate according to Westergren (normal <15 mm/h), C reactive protein (normal <10 mg/i), and haptoglobin (normal 0-2-1'4 g/l). Cell numbers and differential cell counting were performed on synovial fluids with routine methods.
STATISTICS
For statistical evaluation of differences between groups Student's t test was used. Linear correlation analysis of data was used as indicated.
Results Table 2 presents the plasma and synovial fluid concentrations of hypoxanthine, xanthine, and urate in patients with inflammatory arthritides. The mean synovial fluid concentrations of all oxypurine metabolites were higher in synovial fluid than in plasma. The plasma concentrations of hypoxanthine, xanthine, and urate were slightly higher in the patient group than in the healthy controls (table 2), but only the increase in plasma hypoxanthine reached significance (p<0-001). The measured metabolites in plasma or synovial fluid were not related to sex, age, or disease duration.
A weak relation was noted between the estimated effusion of knee joint and synovial fluid concentrations of hypoxanthine (r=0-56, p<005) and xanthine (r=0-052, p<005) respectively. Other subjective or objective clinical estimates of the arthritic condition were not related to the oxypurine metabolites in synovial fluid or plasma, except for a weak relation between morning stiffness and plasma urate (r=0-58, p<0 05). The x ray findings were discrete in most patients and only four had cartilage reduction but no destruction of the knee joint. The measured oxypurine concentrations were not related to the x ray findings.
The median erythrocyte sedimentation rate was 27 mm/h (range 5-120) and median C reactive protein 19 mg/l (range <10-50). Mean (SD) haptoglobin was 3-2 (1-0) g/l (range 1 28-4'24). Except for a weak correlation between synovial fluid urate and serum haptoglobin (r=0-52, p<005) we found no relation between the concentrations of oxypurine metabolites and laboratory signs of systemic inflammatory activity. The local joint inflam- . r r s -670 '1-1.
Oxypurines in ynovialfluid (fig 2) and urate (fig 3) respectively. The hypoxanthine concentrations in synovial fluid were not related to those in plasma (table  2) . Discussion By using high performance liquid chromatography we found increased plasma concentrations of the oxypurine hypoxanthine in patients with rheumatoid arthritis and other inflammatory arthritides; this is in accordance with a previous report. 9 We also found that the synovial fluid concentrations of hypoxanthine, xanthine, and urate were greater than the corresponding plasma concentrations. An increase of hypoxanthine in inflamed synovial fluid in relation to plasma has previously been noted in patients with rheumatoid arthritis but not in osteoarthritis.9 These data suggest that the inflamed joint is a compartment with an enhanced nucleotide metabolism and that diffusion of purine metabolites occurs from the joint to the blood circulation. The strong correlations found between xanthine and urate concentrations in plasma and synovial fluid, respectively, suggest that the inflamed joint contributes significantly to the circulating concentrations of measured oxypurines. The concentrations of hypo-xanthine, xanthine, or urate in plasma or synovial fluid were not related to the disease duration or x ray findings of the joints. Except for a weak correlation between synovial fluid urate and serum haptoglobin we found no relation between the laboratory markers of inflammatory activity and oxypurine concentrations in plasma or synovial fluid.
During catabolism hypoxanthine is converted to xanthine and then to urate by xanthine oxidase. If this enzyme was absent in the joint, xanthine and hypoxanthine would be the end products of purine metabolism of the joint, rather than urate. Xanthine oxidase was previously thought to be almost exclusively found in the liver and intestinal mucosa in man.'2 The presence of increased concentrations of xanthine oxidase was recently reported in the synovial tissue from patients with rheumatoid arthritis. 3 In our study the ratio between synovial fluid and plasma concentrations of xanthine and urate was found to be > 1-0, which may support the presence of xanthine oxidase within the inflamed joint cavity. The increases of the synovial fluid concentrations were fairly small, however, compared with the plasma concentrations and the differences may partly be due to analytical differences in processing two different biological materials. One possible source of xanthine oxidase in the inflamed joint cavity might be the large number of invading inflammatory cells. We found no correlation between the cell counts or the appearance of oxypurines in synovial fluid, however.
Purine metabolites in inflamed synovial fluid may result from adenosine 5-triphosphate catabolism in senescent joint cells like neutrophils, lymphocytes, or cells from pannus. Degradation of DNA and other cellular substances containing purine metabolites may also occur in necrotic lesions of the inflamed synovia. Finally, the appearance of increased concentrations of purine bases in synovial fluid may be due to ischaemia in joint structures.
It has been known for several years that increased catabolism of nucleotides occurs during tissue hypoxia.'4 15 Hypoxanthine in plasma has been proposed to be a good indicator of tissue hypoxia. 16 17 Local accumulation of degradation products from the nucleotide pool is also reported to occur in ischaemic organs. Clinical studies in patients with cerebral ischaemia have reported considerable increases of hypoxanthine and xanthine concentrations in the cerebrospinal fluid.'8 During persistent synovial inflammation with effusion, hypoxia in the synovial cavity is reported.'9 Reduction of the oxygen tension has been attributed to pressure changes induced by exercise. The blood supply to the synovium is supposed to be transiently reduced owing to the increased pressure. Thus the appearance of increased synovial fluid concentrations of hypoxanthine, xanthine, and urate may reflect ischaemic damage in the joint due to increased joint pressure. In support of this hypothesis we found that the estimated effusion of the investigated knee joint correlated with its synovial fluid concentrations of hypoxanthine and xanthine. The tissue damage associated with tenporary ischaemia may partly be dependent on 'the production of free radicals by the
